Method | Detected | Primary antibody | (μg/ml) | secondary antibody | (μg/ml) |
---|---|---|---|---|---|
 | protein |  |  |  |  |
IB | Survivin | pAB AF886 (R&D Systems) | 1,0 | Polyclonal immunoglobulins/HRP-conjugated (DAKO) | 0,3 |
IB | Survivin | pAB 500.201 (Novus Biologicals) | 1,0 | Polyclonal immunoglobulins/HRP-conjugated (DAKO) | 0,5 |
IF | Survivin | pAB AF886 (R&D Systems) | 10,0 | Red fluorescent dye-labeled immunoglobulin (Invitrogen) | 10,0 |
IF | Survivin | pAB 500.201 (Novus Biologicals) | 10,0 | Red fluorescent dye-labeled immunoglobulin (Invitrogen) | 8,0 |
IF | Survivin | mAB clone 60.11 (Novus Biologicals) | 6,0 | Red fluorescent dye-labeled immunoglobulin (Invitrogen) | 8,0 |